Finance

Lists
330350:KOSDAQ
Withus Pharmaceutical Co Ltd
6 780,00 ₩
+0,74%
(+50,00) 1D
11 նոյ, 15:30:18 GMT+9  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 330350...
Open
6 730 ₩
High
6 900 ₩
Low
6 580 ₩
Mkt. cap
89,49 մլրդ
Avg. vol.
141,02 հզր
Volume
104,85 հզր
P/E ratio
11,24
52-wk high
11 950 ₩
52-wk low
5 910 ₩
EPS
603 ₩
Shares outstanding
13,20 մլն
No. of employees
218
Open
6 730 ₩
High
6 900 ₩
Low
6 580 ₩
Mkt. cap
89,49 մլրդ
Avg. vol.
141,02 հզր
Volume
104,85 հզր
P/E ratio
11,24
52-wk high
11 950 ₩
52-wk low
5 910 ₩
EPS
603 ₩
Shares outstanding
13,20 մլն
No. of employees
218
News stories
From web sources and news partners
About Withus Pharmaceutical Co Ltd
CEO-
Employees218
Founded2004
Headquarters-
SectorHealth Care
Industry-
Websitewithuspharm.com
Previous reportsAll values in KRW
Loading Previous Earnings...
Revenue
Net income
All values in KRW
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
27,25 մլրդ
27,18 մլրդ
28,22 մլրդ
29,07 մլրդ
Cost of goods sold
9,53 մլրդ
9,88 մլրդ
10,00 մլրդ
10,42 մլրդ
Cost of revenue
9,53 մլրդ
9,88 մլրդ
10,00 մլրդ
10,42 մլրդ
Research and development expenses
-
452,18 մլն
565,05 մլն
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
16,35 մլրդ
15,00 մլրդ
16,79 մլրդ
17,57 մլրդ
Operating expense
16,35 մլրդ
15,92 մլրդ
17,98 մլրդ
17,57 մլրդ
Total operating expenses
25,88 մլրդ
25,80 մլրդ
27,97 մլրդ
28,00 մլրդ
Operating income
1,37 մլրդ
1,38 մլրդ
244,17 մլն
1,08 մլրդ
Other non operating income
1,26 մլրդ
-108,94 մլն
113,80 մլն
1,40 մլրդ
EBT including unusual items
2,63 մլրդ
-1,57 մլրդ
711,51 մլն
2,47 մլրդ
EBT excluding unusual items
2,63 մլրդ
1,26 մլրդ
370,21 մլն
2,47 մլրդ
Income tax expense
483,36 մլն
-1,45 մլրդ
-3,26 մլրդ
505,02 մլն
Effective tax rate
18,39%
92,33%
-458,19%
20,42%
Other operating expenses
-
40,81 մլն
53,43 մլն
-
Net income
2,14 մլրդ
-120,28 մլն
3,97 մլրդ
1,97 մլրդ
Net profit margin
7,87%
-0,44%
14,08%
6,77%
Earnings per share
-
-
-
-
Interest and investment income
-
151,87 մլն
155,00 մլն
-
Interest expense
-
-165,04 մլն
-138,27 մլն
-
Net interest expenses
-
-13,17 մլն
16,73 մլն
-
Depreciation and amortization charges
-
92,72 մլն
149,77 մլն
-
EBITDA
2,41 մլրդ
2,43 մլրդ
1,32 մլրդ
2,16 մլրդ
Gain or loss from assets sale
-
-
-
-
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google Apps